Comparison Study of the Effect of Erlotinib As a Tyrosine Kinase Inhibitor on Electrolyte Levels in Type2 Diabetic and Diabetic Nephropathy. IHJPAS 2018, 31 (3), 63-69. https://doi.org/10.30526/31.3.2011.